highperformr logo

CAMP4 Therapeutics's Overview

Total employees65
HeadquartersCambridge
Founded2016

Camp4 Therapeutics is at the forefront of developing a new class of medicines by targeting regulatory RNAs (regRNAs) to precisely control gene expression. Their proprietary platform aims to unlock the potential of the cellular signaling-regulatory network, enabling the discovery and development of programmable therapeutics for a broad spectrum of genetic and common diseases. By understanding and modulating the 'instruction manual' of gene expression, Camp4 seeks to address conditions previously considered undruggable.

Where is CAMP4 Therapeutics's Headquarters?

HQ Function

Primary research and development laboratories, corporate leadership, and operational hub for pioneering RNA-targeting therapeutics and advancing the company's drug discovery platform.

Notable Features:

Located within the vibrant One Kendall Square campus, offering access to state-of-the-art facilities, a dense network of academic and industry collaborators, and a dynamic environment conducive to cutting-edge scientific research.

Work Culture:

Camp4 fosters a science-driven, innovative, and collaborative work culture. Employees are encouraged to be bold and creative, working together in a fast-paced environment dedicated to translating groundbreaking science into impactful medicines for patients.

HQ Significance:

The Cambridge headquarters is strategically vital, placing Camp4 at the epicenter of biotechnological advancement, facilitating talent acquisition, scientific partnerships, and access to world-class research infrastructure.

Values Reflected in HQ: The headquarters' location and setup reflect Camp4's commitment to scientific excellence, innovation, collaboration, and its mission to tackle challenging diseases through novel therapeutic approaches.

Location:

While Camp4 Therapeutics' primary operations and headquarters are centralized in Cambridge, MA, the company is focused on developing novel medicines with the potential for global impact. Their research, clinical development strategies, and future commercialization efforts are designed to address diseases affecting patient populations worldwide, involving international collaborations and regulatory interactions as their pipeline advances.

Street Address:

One Kendall Square, Building 1400W, Suite 14-201

City:

Cambridge

State/Province:

MA

Country:

USA

CAMP4 Therapeutics's Global Presence

Buying Intent Signals for CAMP4 Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of CAMP4 Therapeutics

As of April 2025, CAMP4 Therapeutics' leadership includes:

Josh Mandel-Brehm - President & Chief Executive Officer
David Bumcrot, PhD - Chief Scientific Officer
Mark D. Licking, PhD - Chief Operating Officer
Ann C. Barbier, MD, PhD - Chief Medical Officer
Kelly G. Copes-Anderson - Chief People Officer
Adam M. Pires - Chief Business & Financial Officer

Investors of CAMP4 Therapeutics

CAMP4 Therapeutics has been backed by several prominent investors over the years, including:

5AM Ventures
Andreessen Horowitz (a16z Bio + Health)
Polaris Partners
Northpond Ventures
GV (Google Ventures)
The Kraft Group
Casdin Capital
Alexandria Venture Investments
Pfizer Ventures
Fidelity Management & Research Company
Yonjin Venture
Vertex Ventures HC

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits0

In the past 12 months, Camp4 Therapeutics has significantly strengthened its executive leadership team with key appointments in finance, medical, and people operations, reflecting its growth and strategic focus. No major executive departures were publicly announced during this period.

New Appointments:

Adam M. Pires, Adam M. Pires appointed as Chief Business & Financial Officer to oversee financial operations and business development.
Ann C. Barbier, MD, PhD, Dr. Ann C. Barbier appointed as Chief Medical Officer, bringing deep expertise in clinical development to Camp4.
Kelly G. Copes-Anderson, Kelly G. Copes-Anderson appointed as Chief People Officer to lead people strategy and enhance organizational development.

Technology (Tech Stack) used by CAMP4 Therapeutics

Discover the tools CAMP4 Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

CAMP4 Therapeutics Email Formats and Examples

Camp4 Therapeutics commonly uses the first initial followed by the last name for their email addresses. This is a frequent pattern in many biotechnology and corporate environments.

[first_initial][last]@camp4tx.com

Format

jdoe@camp4tx.com

Example

90%

Success rate

News and media

Business WireApril 3, 2024

Camp4 Therapeutics to Present New Preclinical Data for its Lead RNA Activator, CMP4-001, at the 2024 American Academy of Neurology (AAN) Annual Meeting

Camp4 Therapeutics announced it will present new preclinical data for CMP4-001, its lead RNA activator targeting Dravet syndrome and other SCN1A-related epilepsies, at the AAN 2024 Annual Meeting....more

Business WireDecember 12, 2023

Camp4 Therapeutics Appoints Adam Pires as Chief Business and Financial Officer

Camp4 Therapeutics announced the appointment of Adam M. Pires as its Chief Business and Financial Officer, effective January 2024....more

Business WireJune 28, 2023

Camp4 Therapeutics Appoints Ann Barbier, M.D., Ph.D., as Chief Medical Officer

Camp4 Therapeutics announced the appointment of Ann C. Barbier, M.D., Ph.D., as its Chief Medical Officer....more

Business WireMay 10, 2023

Camp4 Therapeutics Appoints Kelly G. Copes-Anderson as Chief People Officer

Camp4 Therapeutics announced the appointment of Kelly G. Copes-Anderson as its Chief People Officer....more

Business WireFebruary 7, 2023

Camp4 Therapeutics Announces $100 Million Oversubscribed Series B Extension Financing

Camp4 Therapeutics announced the closing of an oversubscribed $100 million Series B extension financing round, co-led by existing investor Northpond Ventures and a new, undisclosed global life sciences investor....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including CAMP4 Therapeutics, are just a search away.